Preparing a submission for Cancer Biotherapy and Radiopharmaceuticals
Cancer Biotherapy and Radiopharmaceuticals sets its own submission rules: length and word limits, the required citation and reference style, figure and table formatting, and editorial policies. Scraiber tracks 9 requirements for Cancer Biotherapy and Radiopharmaceuticals and rewrites your manuscript to meet each one.
Instead of checking each rule by hand, import your draft into Scraiber, select Cancer Biotherapy and Radiopharmaceuticals, and let it rewrite your text to match: the exact word limits, reference style and structure, so your paper is submission-ready.
If the paper was rejected elsewhere, most of the work in retargeting Cancer Biotherapy and Radiopharmaceuticals is mechanical: the reference style changes, headings and sections move, word and abstract limits differ, and the declarations have to follow Cancer Biotherapy and Radiopharmaceuticals's own template. Scraiber applies those changes to the draft you already have instead of you rebuilding the manuscript by hand.
What Cancer Biotherapy and Radiopharmaceuticals specifies
These are the areas Cancer Biotherapy and Radiopharmaceuticals writes rules for. Scraiber holds the exact value behind each one and applies it to your draft.
- Citations & references 1 rule: citation style.
- Formatting & submission 8 rules: author contributions, competing interests, contributor roles, cover letter, data availability, ethics statement, in text citation format, line spacing.
What Scraiber changes in your manuscript
Scraiber rewrites the parts of your draft that Cancer Biotherapy and Radiopharmaceuticals constrains: it brings sections within the required lengths, converts in-text citations and the bibliography to the required style, adjusts headings and structure, and flags the declarations Cancer Biotherapy and Radiopharmaceuticals expects. Your argument, results and voice stay yours — only what the journal dictates changes.
Frequently asked questions
- What are the submission requirements for Cancer Biotherapy and Radiopharmaceuticals?
- Cancer Biotherapy and Radiopharmaceuticals has 9 documented author requirements covering length limits, citation style, figures, tables and submission policies. Sign in to Scraiber to see each exact value and rewrite your manuscript to match.
- Which citation style does Cancer Biotherapy and Radiopharmaceuticals use?
- Scraiber tracks Cancer Biotherapy and Radiopharmaceuticals's required reference style and reformats your citations to it automatically. Open the journal in Scraiber to apply it to your document.
- Can I automatically format my paper for Cancer Biotherapy and Radiopharmaceuticals?
- Yes. Paste or import your draft into Scraiber, pick Cancer Biotherapy and Radiopharmaceuticals, and it rewrites your text to meet the journal's requirements: length, references, structure and more.
- How do I reformat a paper rejected by another journal for Cancer Biotherapy and Radiopharmaceuticals?
- Import the manuscript you already submitted elsewhere, select Cancer Biotherapy and Radiopharmaceuticals, and Scraiber rewrites it against Cancer Biotherapy and Radiopharmaceuticals's requirements: reference style, length limits, structure and declarations. You never start from a blank page.
- How long does it take to prepare a manuscript for Cancer Biotherapy and Radiopharmaceuticals?
- Minutes rather than an evening. The rewrite runs on your existing draft, so what disappears is the manual pass over every formatting rule.
- Do I have to redo my references for Cancer Biotherapy and Radiopharmaceuticals?
- No. Scraiber converts your existing citations and bibliography to the reference style Cancer Biotherapy and Radiopharmaceuticals requires, including the in-text citation format.
Official author guidelines: liebertpub.com